Abbott Indiaの価格/販売
Abbott Indiaの価格/販売は何ですか。
Abbott India Limitedの価格/販売は8.19です。
価格/販売の定義は何ですか。
価格対売上比率は、収益と比較した会社の株価です。
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
NSEのセクタHealth Careにおける価格/販売の企業と比べるAbbott India
Abbott Indiaは何をしますか。
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
Abbott Indiaと類似の価格/販売
- ServisFirst Bancshares Incの価格/販売は8.17です。
- TriplePoint Venture Growth BDC Corpの価格/販売は8.17です。
- Aurinia Pharmaceuticalsの価格/販売は8.18です。
- Atrium Mortgage Investmentの価格/販売は8.18です。
- Smart Metering Systems Plcの価格/販売は8.18です。
- WPT Industrial Real Estate Investment Trustの価格/販売は8.19です。
- Abbott Indiaの価格/販売は8.19です。
- Vision Cinemasの価格/販売は8.19です。
- Pfizerの価格/販売は8.19です。
- The Scottish Oriental Smaller Cos. Trust Plcの価格/販売は8.20です。
- Thomson Reutersの価格/販売は8.20です。
- Jiumaojiu Internationalの価格/販売は8.20です。
- Lithium Australia NLの価格/販売は8.20です。